The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable

Wednesday, July 27, 2011

Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable06:00 EDT Wednesday, July 27, 2011 SAN DIEGO (Business Wire) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Leerink Swann Life Science Tools and Diagnostics Roundtable in New York, New York, on August 3, 2011. The live webcast is scheduled to begin at 1:50 p.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer. The live webcast can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com. About Illumina Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare. Illumina, Inc.Investors:Kevin Williams, MDInvestor Relations858-332-4989kwilliams@illumina.comorMedia:Laura TrotterPublic Relations858-882-6822PR@illumina.com